Does GLP-1 Liquid Work? What the Evidence Says (October 2026)

01 · The verdict

Does GLP-1 liquid work? The verdict

Does GLP-1 liquid work? Not in the way its marketing suggests. A GLP-1 liquid sold online as drops, a tonic or a drink mix is a supplement-style product. It is not the licensed prescription medicine that the clinical trials tested. A bottle labelled 'GLP-1' does not share the evidence of a licensed GLP-1 treatment, in the same way that a bottle labelled 'insulin support' is not insulin.

The names cause real confusion. Licensed GLP-1 medicines act on gut-hormone receptors in a controlled, measured way. A product that uses the term in its name may contain ingredients that claim to 'support' your own GLP-1, or nothing of the kind. Dosing is not standardised, and there is no regulator-approved patient leaflet explaining what it does. Our guide to liquid GLP-1 products and weight loss goes deeper on the marketing claims.

If your goal is to lose weight with a medicine that has been properly studied, the real choice is between licensed treatments. These are prescribed after a consultation, reviewed by a prescriber and supplied by a registered pharmacy.

The low cost of these liquids is a reason for caution, not a bargain. You are paying for a promise, not for a treatment that has been shown to work.

02 · What to do next

Where this leaves you

You are probably facing one of two decisions. The first is whether to try a liquid product anyway. We would not, because the downside is wasted money and a delay in getting proper treatment, and there is no trial-backed upside. The second is whether you are a suitable candidate for a licensed GLP-1 medicine. That depends on your BMI, your health history and your goals, and a prescriber is the right person to judge it.

For adults who meet the licensed criteria, the Mounjaro pen starts at £169.99 per month for the 2.5mg starter pen. New customers save £40 on their first order with code FIRST40, and an automatic £25 reorder discount applies to every future order (code DOSE25). Prices checked 10 October 2026. Our weight loss clinic page explains the options, and the consultation is free with no obligation.

03 · What 'GLP-1 liquid' means

What people mean by GLP-1 liquid

'GLP-1 liquid' is not a single product, which is why the answer to 'does it work' is so muddy. The phrase is used for several different things, and it helps to separate them before judging any of them.

The first group is oral drops, sprays and tinctures sold as weight-loss aids. Sellers often describe them as 'GLP-1 support' or a 'natural GLP-1 booster'. The second group is drink mixes and powders that you stir into water, sometimes called a 'GLP-1 drink'.

Both groups are consumer products. Our page on GLP-1 liquid products looks at what is typically on the label and what the labels leave out. The key thing to notice is the gap between the name and the evidence. A label may say 'GLP-1' without containing any licensed GLP-1 medicine, and without any published trial that tested that exact formulation.

A fair test of any product is simple. Ask whether it has a patient information leaflet approved by a medicines regulator. Ask whether a prescriber reviews you before you can buy it. Ask whether it names a trial in which that exact product was tested. If the answer to all three is no, you are looking at marketing, not medicine.

04 · How real GLP-1 treatment works

How a licensed GLP-1 medicine actually works

A licensed GLP-1 medicine works by acting on gut-hormone receptors, and that is what makes it different from a liquid that merely mentions the hormone. Tirzepatide, the active ingredient in Mounjaro, is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ That is the whole mechanism in plain terms: it changes appetite signals, and the diet change does the rest. It is not a fat-melting liquid or a metabolism 'switch'.

Mounjaro is a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

The point for anyone comparing options is that every part of this is controlled: the molecule, the dose, the pen, the schedule and the review. A liquid supplement offers none of those controls. If you want to see how a prescribed tablet differs from an injection, our explainer on how Foundayo works describes the oral route in simple terms.

05 · What the evidence shows

What the trial evidence actually covers

The published evidence for GLP-1 weight loss belongs to specific licensed medicines, not to liquids with similar-sounding names. The headline example for tirzepatide is the SURMOUNT-1 trial. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² That caveat matters for how you read any weight-loss claim. If a product page quotes a dramatic figure, ask which trial it came from, which product was tested and for how long.

A liquid cannot borrow these results. The numbers belong to tirzepatide, given by injection at set doses, to adults who were monitored throughout. Quoting them beside a drink mix is, at best, misleading.

Beyond the scales, the same trial work found wider changes. In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.² These are trial-average secondary outcomes, not promises. They show what a properly studied medicine can be tested for. A supplement with no trial cannot show any of it.

06 · Is GLP-1 liquid safe?

Is GLP-1 liquid safe?

Safety is the part of this topic that gets least attention and matters most. A given bottle of GLP-1 liquid cannot be assumed safe, because the contents are not standardised and nobody has reviewed your health history before you buy it. That is a different risk profile from a prescription medicine supplied by a registered pharmacy.

There are several practical concerns. The first is unknown contents: the amount and purity of what is inside may not match the label. The second is unknown interactions, because a product you take without telling any clinician cannot be checked against your existing medicines. The third is the lack of a safety net. A licensed medicine comes with an approved leaflet that lists side effects and says when to seek help. A product sold online may not.

The fourth concern is false reassurance. A person who takes a liquid and sees nothing happen may decide GLP-1 treatment 'does not work for them', when in fact they never received any. That can delay a proper conversation with a prescriber.

The medicines regulator publishes counterfeit medicine alerts and runs the Yellow Card scheme for reporting suspected side effects.⁷ If you have taken a product and had a reaction, you can report it through the Yellow Card scheme.¹⁹ Reports like these help the regulator spot problems with products that would otherwise go unnoticed.

Be especially wary of any seller offering to supply a GLP-1 product without a consultation or prescription. A legitimate prescription medicine is never sold that way.

07 · Who should avoid GLP-1 medicines

Who should not take a GLP-1 medicine

Licensed GLP-1 medicines are not suitable for everyone, which is exactly why a prescriber reviews you first. Mounjaro is not suitable if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive.¹ Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly.

Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Always share your full medical history and medicine list during consultation.¹

There are also thyroid questions. In rodent studies tirzepatide caused thyroid C-cell tumours; it is not known whether this applies to humans, and no increase has been shown in human trials. As a precaution, tell your prescriber if you or a close relative have had medullary thyroid cancer or the inherited condition MEN 2.¹

Insulin and sulfonylureas deserve a mention too. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

None of this screening happens when you buy a liquid from a website. That is the practical answer to 'who should not take it': anyone, until a clinician has looked at their history. The NHS also publishes its own tirzepatide information for patients.⁵

08 · Serious side effects to know

Side effects that need urgent attention

Serious side effects of licensed GLP-1 medicines are uncommon, but you should know the warning signs. Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis). Seek immediate medical help for pain in the upper right abdomen, fever or yellowing of skin or eyes (possible gallbladder problems), or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing.¹

Day to day, the commonest early effects are milder. Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.¹

Two further points are worth stating. Mounjaro is not known to damage kidneys or liver directly, but severe vomiting or diarrhoea can cause dehydration, which can strain the kidneys, so keep fluids up and get medical help straight away if you cannot keep fluids down. On mood, regulators have looked specifically at whether GLP-1 medicines are linked to low mood or suicidal thoughts. The EMA's safety committee concluded that the evidence does not support a causal link, and the MHRA keeps this under continuous review.¹ Even so, tell your prescriber about any history of depression, and seek help promptly if your mood drops during treatment.

If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro.

The value of a licensed route is that these warnings are written down, supported by a clinical team and tied to a named medicine. Someone using an unregulated liquid has no equivalent guidance for the symptoms they might actually get.

09 · Realistic results and plateaus

What realistic results look like on a licensed medicine

Weight loss on a licensed GLP-1 medicine is gradual by design, and any product promising rapid results should raise suspicion. The first weeks on 2.5mg are an adjustment phase and losses are usually modest; most measurable progress builds from 5mg onward, month by month. Trials measured results at 72 weeks — think in months, not days, and judge progress by trend, not individual weigh-ins.²

Early experience varies widely. Some people notice appetite change and early loss in week one, others feel little until a higher dose, and both are normal. Early loss includes water weight, so the trend over weeks matters more than any single weigh-in.²

Plateaus happen too. Weight loss on Mounjaro is not linear — plateaus of a few weeks are normal and expected as the body adapts to a lower weight. Within the licence, the responses are to review food intake honestly (portions drift back up), protect protein and activity, check the basics (sleep, alcohol), and discuss with your prescriber whether a dose step-up is appropriate if you are not yet at maximum. A plateau is not a reason to double doses or add unlicensed products.¹

Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹ That structured review is something a liquid supplement cannot offer. It is also the honest answer to 'why am I not losing weight on GLP-1': the first step is a clinical review, not a new product.

10 · Oral options that are licensed

If you want something other than an injection

If the appeal of a liquid is avoiding needles, there are licensed oral GLP-1 options, but they are prescription medicines and not liquids sold online. Wegovy tablets (oral semaglutide) and Foundayo (orforglipron) are film-coated tablets, each with its own product information on the electronic medicines compendium.²⁰²¹

The injectable alternative to Mounjaro is the Wegovy pen. Wegovy (semaglutide) comes in pens of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg once weekly. The dose steps up after at least four weeks, reaching the 2.4mg maintenance dose from week 17, and 2.4mg is the licensed maintenance dose for weight management.¹⁸ Liraglutide, supplied at 6mg/ml, is a daily injection rather than a weekly one.

For oral questions in particular, see the guide on oral liquid GLP-1 claims.

11 · NHS and private routes

Getting a licensed GLP-1 medicine: NHS and private

You can get a licensed GLP-1 medicine through the NHS or privately, and neither route involves buying drops from a website. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶

Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting. Wegovy access on the NHS runs through specialist weight-management services; ask your GP.

A private route should still involve a clinician. With us, the journey runs as follows. You complete a free online consultation, a short health questionnaire with no charge and no obligation. A GPhC-registered prescriber reviews it; payment is taken when you place the order, and if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Our registered pharmacy dispenses the medicine, with same-day dispatch when ordered by 3pm. Delivery is free, next-day, tracked and temperature-controlled, and Saturday delivery is £14.99.

Mounjaro is supplied through official LillyDirect supply, sourced directly from Eli Lilly, and all six doses are in stock. Ongoing monthly reviews are included, and repeat orders re-check suitability, with no auto-shipping. You can check our registration on the GPhC register (GPhC 9012878).